EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement

M Carbone, A Della Penna, C Mazzarelli, E De Martin, C Villard, A Bergquist, P D Line, J M Neuberger, S Al-Shakhshir, P J Trivedi, U Baumann, L Cristoferi und 8 weitere

Transplant International · 29.09.2023 · 36

DOI: 10.3389/ti.2023.11729 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant International, online erschienen am 29.09.2023. Verfasst von M Carbone und 19 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Autoimmune Liver Diseases, Department of Medicina and Surgery, University of Milano-Bicocca, Milan, Italy. Hauptthemen laut MEDLINE: Liver Transplantation, Cholangitis, Sclerosing, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary sclerosing cholangitis (PSC) is the classical hepatobiliary manifestation of inflammatory bowel disease (IBD) and a lead indication for liver transplantation (LT) in the western world. In this article, we present a Consensus Statement on LT practice, developed by a dedicated Guidelines’ Taskforce of the European Society of Organ Transplantation (ESOT). The overarching goal is to provide practical guidance on commonly debated topics, including indications and timing of LT, management of bile duct stenosis in patients on the transplant waiting list, technical aspects of transplantation, immunosuppressive strategies post-transplant, timing and extension of intestinal resection and futility criteria for re-transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationCholangitis, SclerosingInflammatory Bowel DiseasesHumansRisk FactorsImmunosuppressive Agents

Stichwörter der Autor:innen

IBDPSCimmunosuppressionliver transplantationretransplantation

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Centre for Autoimmune Liver Diseases, Department of Medicina and Surgery, University of Milano-Bicocca, Milan, Italy.
  • European Reference Network on Hepatological Diseases (ERN RARE-LIVER), IRCCS San Gerardo dei Tintori, Monza, Italy.
  • Department of General, Visceral and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany.
  • Hepatology and Gastroenterology Unit, ASST GOM Niguarda, Milan, Italy.
  • AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, Inserm Unité 1193, Université Paris-Saclay, FHU Hépatinov, Centre de Référence Maladies Inflammatoires des Voies Biliaires et Hépatites Auto-Immunes, Villejuif, France.
  • Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.

Zitieren

APA

Carbone, M., Della Penna, A., Mazzarelli, C., De Martin, E., Villard, C., Bergquist, A., Line, P. D., Neuberger, J. M., Al-Shakhshir, S., Trivedi, P. J., Baumann, U., Cristoferi, L., Hov, J., Fischler, B., Hadzic, N. H., Debray, D., D'Antiga, L., Selzner, N., Belli, L. S., & Nadalin, S. (2023). Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement. Transplant International, 36. https://doi.org/10.3389/ti.2023.11729

Vancouver

Carbone M, Della Penna A, Mazzarelli C, De Martin E, Villard C, Bergquist A, et al. Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement. Transplant International. 2023;36. doi:10.3389/ti.2023.11729

BibTeX
@article{Carbone2023,
  author = {Carbone, M and Della Penna, A and Mazzarelli, C and De Martin, E and Villard, C and Bergquist, A and Line, P D and Neuberger, J M and Al-Shakhshir, S and Trivedi, P J and Baumann, U and Cristoferi, L and Hov, J and Fischler, B and Hadzic, N H and Debray, D and D'Antiga, L and Selzner, N and Belli, L S and Nadalin, S},
  title = {Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement},
  journal = {Transplant International},
  year = {2023},
  volume = {36},
  doi = {10.3389/ti.2023.11729}
}
Kostenlos starten →